Clinical Effectiveness of Fixed Dose Combination of Empagliflozin And Linagliptin (EMPA/LINA) In Patients with Type 2 Diabetes Mellitus Unwilling To Continue Basal Insulin Therapy: A Real–World Experience In Indian Setting - Current Issue

Clinical Effectiveness of Fixed Dose Combination of Empagliflozin And Linagliptin (EMPA/LINA) In Patients with Type 2 Diabetes Mellitus Unwilling To Continue Basal Insulin Therapy: A Real–World Experience In Indian Setting - Current Issue - IJAR